Cannabinoids in chronic non-cancer pain medicine: moving from the bench to the bedside.
作者信息
Meng H, Deshpande A
机构信息
University of Toronto, Toronto, ON, Canada.
University Health Network, Toronto, ON, Canada.
出版信息
BJA Educ. 2020 Sep;20(9):305-311. doi: 10.1016/j.bjae.2020.05.002. Epub 2020 Jul 21.
Abstract
摘要
相似文献
1
Cannabinoids in chronic non-cancer pain medicine: moving from the bench to the bedside.
BJA Educ. 2020 Sep;20(9):305-311. doi: 10.1016/j.bjae.2020.05.002. Epub 2020 Jul 21.
2
, the Endocannabinoid System and Immunity-the Journey from the Bedside to the Bench and Back.
Int J Mol Sci. 2020 Jun 23;21(12):4448. doi: 10.3390/ijms21124448.
3
Cannabinoids for Treatment of MS Symptoms: State of the Evidence.
Curr Neurol Neurosci Rep. 2018 Jun 19;18(8):50. doi: 10.1007/s11910-018-0859-x.
4
Cannabis and cannabinoids: pharmacology and rationale for clinical use.
Forsch Komplementarmed. 1999 Oct;6 Suppl 3:12-5. doi: 10.1159/000057150.
5
State of the science: cannabis and cannabinoids in palliative medicine-the potential.
BMJ Support Palliat Care. 2021 Sep;11(3):299-302. doi: 10.1136/bmjspcare-2021-002888. Epub 2021 Apr 26.
6
Cannabinoids in the treatment of pain and spasticity in multiple sclerosis.
Curr Opin Investig Drugs. 2002 Jun;3(6):859-64.
7
Cannabis and Cannabinoids for Chronic Pain.
Curr Rheumatol Rep. 2017 Oct 5;19(11):67. doi: 10.1007/s11926-017-0693-1.
8
Understanding the evidence for medical cannabis and cannabis-based medicines for the treatment of chronic non-cancer pain.
Eur Arch Psychiatry Clin Neurosci. 2019 Feb;269(1):135-144. doi: 10.1007/s00406-018-0960-9. Epub 2019 Jan 11.
9
Medical cannabis and cannabinoids in rheumatology: where are we now?
Expert Rev Clin Immunol. 2019 Oct;15(10):1019-1032. doi: 10.1080/1744666X.2019.1665997.
10
Cannabinoids and Pain: New Insights From Old Molecules.
Front Pharmacol. 2018 Nov 13;9:1259. doi: 10.3389/fphar.2018.01259. eCollection 2018.
引用本文的文献
1
How Biodegradable Polymers Can be Effective Drug Delivery Systems for Cannabinoids? Prospectives and Challenges.
Int J Nanomedicine. 2024 May 22;19:4607-4649. doi: 10.2147/IJN.S458907. eCollection 2024.
2
Tetrahydrocannabinol and Cannabidiol for Pain Treatment-An Update on the Evidence.
Biomedicines. 2024 Jan 29;12(2):307. doi: 10.3390/biomedicines12020307.
3
Differential Effects of Cannabidiol and a Novel Cannabidiol Analog on Oxycodone Place Preference and Analgesia in Mice: an Opioid Abuse Deterrent with Analgesic Properties.
Cannabis Cannabinoid Res. 2022 Dec;7(6):804-813. doi: 10.1089/can.2021.0050. Epub 2021 Dec 24.
本文引用的文献
1
Prevalence and forms of cannabis use in legal vs. illegal recreational cannabis markets.
Int J Drug Policy. 2020 Feb;76:102658. doi: 10.1016/j.drugpo.2019.102658. Epub 2020 Jan 9.
2
Cannabidiol Counteracts the Psychotropic Side-Effects of Δ-9-Tetrahydrocannabinol in the Ventral Hippocampus through Bidirectional Control of ERK1-2 Phosphorylation.
J Neurosci. 2019 Oct 30;39(44):8762-8777. doi: 10.1523/JNEUROSCI.0708-19.2019. Epub 2019 Sep 30.
3
Association of Cannabinoid Administration With Experimental Pain in Healthy Adults: A Systematic Review and Meta-analysis.
JAMA Psychiatry. 2018 Nov 1;75(11):1118-1127. doi: 10.1001/jamapsychiatry.2018.2503.
4
Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain.
Pain. 2019 Jan;160(1):136-150. doi: 10.1097/j.pain.0000000000001386.
5
Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: a systematic review and meta-analysis of controlled and observational studies.
Pain. 2018 Oct;159(10):1932-1954. doi: 10.1097/j.pain.0000000000001293.
6
Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System.
Int J Mol Sci. 2018 Mar 13;19(3):833. doi: 10.3390/ijms19030833.
7
Practical considerations in medical cannabis administration and dosing.
Eur J Intern Med. 2018 Mar;49:12-19. doi: 10.1016/j.ejim.2018.01.004. Epub 2018 Jan 4.
8
Current evidence of cannabinoid-based analgesia obtained in preclinical and human experimental settings.
Eur J Pain. 2018 Mar;22(3):471-484. doi: 10.1002/ejp.1148. Epub 2017 Nov 21.
9
An Update on Non-CB, Non-CB Cannabinoid Related G-Protein-Coupled Receptors.
Cannabis Cannabinoid Res. 2017 Oct 1;2(1):265-273. doi: 10.1089/can.2017.0036. eCollection 2017.
10
Efficacy, tolerability and safety of cannabis-based medicines for chronic pain management - An overview of systematic reviews.
Eur J Pain. 2018 Mar;22(3):455-470. doi: 10.1002/ejp.1118. Epub 2017 Oct 15.
Zotero 插件